speb/financial-data huggingface dataset:
ORGO cash_flow (quarterly, 2025-06-30) — Changes In Cash: -36799000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Common Stock: 13000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 233242000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Construction In Progress: 23936000.00
ORGO income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 27630000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 5578000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Current Assets: 260223000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 9768000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 9768000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 2680000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 2680000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 65839000.00
ORGO cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -1026000.00
ORGO cash_flow (quarterly, 2025-06-30) — Deferred Tax: -1026000.00
ORGO cash_flow (quarterly, 2025-06-30) — Depreciation: 5814000.00
ORGO cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 6655000.00
ORGO cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 6655000.00
ORGO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 126853536.00
ORGO income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.10
ORGO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -12202000.00
ORGO income_statement (quarterly, 2025-06-30) — EBIT: -10830000.00
ORGO income_statement (quarterly, 2025-06-30) — EBITDA: -4175000.00
ORGO cash_flow (quarterly, 2025-06-30) — End Cash Position: 73735000.00
ORGO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -288000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Finished Goods: 18298000.00
ORGO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -36511000.00
ORGO cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: 25000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Goodwill: 28772000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 39557000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 131535000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Gross PPE: 190965000.00
ORGO income_statement (quarterly, 2025-06-30) — Gross Profit: 73149000.00
ORGO income_statement (quarterly, 2025-06-30) — Impairment Of Capital Assets: 1746000.00
ORGO cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 3641000.00
ORGO income_statement (quarterly, 2025-06-30) — Interest Income: 669000.00
ORGO income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 669000.00
ORGO cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 0.00
ORGO balance_sheet (quarterly, 2025-06-30) — Inventory: 33042000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 233242000.00
ORGO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -3638000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Leases: 66773000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 31048000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 31048000.00
ORGO cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -288000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 64999000.00
ORGO income_statement (quarterly, 2025-06-30) — Net Income: -9392000.00
ORGO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -12202000.00
ORGO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -9392000.00
ORGO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -9392000.00
ORGO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -9392000.00
ORGO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -9392000.00
ORGO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -9392000.00
ORGO income_statement (quarterly, 2025-06-30) — Net Interest Income: 669000.00
ORGO cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -288000.00
ORGO cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -288000.00
ORGO income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 669000.00
ORGO cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: 0.00
ORGO balance_sheet (quarterly, 2025-06-30) — Net PPE: 110864000.00
ORGO cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -3638000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 321662000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 41754000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 41754000.00
ORGO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -2429000.00
ORGO income_statement (quarterly, 2025-06-30) — Normalized Income: -8006295.08
ORGO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -32873000.00
ORGO cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 25000.00
ORGO income_statement (quarterly, 2025-06-30) — Operating Income: -10830000.00
ORGO income_statement (quarterly, 2025-06-30) — Operating Revenue: 100779000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 126853536.00
ORGO balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 27777000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 1291000.00
ORGO income_statement (quarterly, 2025-06-30) — Other Income Expense: -1673000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 10785000.00
ORGO cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 2454000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 8730000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 3022000.00
ORGO income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 73000.00
ORGO income_statement (quarterly, 2025-06-30) — Other Operating Expenses: -226000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Other Properties: 35257000.00
ORGO income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 129000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Payables: 29898000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 35476000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 16624000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 127977000.00
ORGO income_statement (quarterly, 2025-06-30) — Preferred Stock Dividends: 2681000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Preferred Stock Equity: 127977000.00
ORGO income_statement (quarterly, 2025-06-30) — Pretax Income: -11834000.00
ORGO cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 0.00
ORGO balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
ORGO cash_flow (quarterly, 2025-06-30) — Provisionand Write Offof Assets: 2243000.00
ORGO cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -3638000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Raw Materials: 13919000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Receivables: 120382000.00
ORGO income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 27630000.00
ORGO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 6655000.00
ORGO cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -288000.00
ORGO income_statement (quarterly, 2025-06-30) — Research And Development: 10395000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 659000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -68345000.00
ORGO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 73810000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Share Issued: 127582084.00
ORGO income_statement (quarterly, 2025-06-30) — Special Income Charges: -1746000.00
ORGO cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 2542000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 361219000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 193685000.00
ORGO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -360295.08
ORGO income_statement (quarterly, 2025-06-30) — Tax Provision: -2442000.00
ORGO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
ORGO balance_sheet (quarterly, 2025-06-30) — Total Assets: 461128000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 361219000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Total Debt: 40816000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 361219000.00
ORGO income_statement (quarterly, 2025-06-30) — Total Expenses: 111609000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 99909000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 200905000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 34070000.00
ORGO income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -12576000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 175000.00
ORGO income_statement (quarterly, 2025-06-30) — Total Unusual Items: -1746000.00
ORGO income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -1746000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 728548.00
ORGO balance_sheet (quarterly, 2025-06-30) — Work In Process: 825000.00
ORGO balance_sheet (quarterly, 2025-06-30) — Working Capital: 194384000.00
ORGO income_statement (quarterly, 2025-06-30) — Write Off: 0.00
ORGO income_statement (quarterly, 2025-09-30) — +Operating Expense: 92587000.00
ORGO income_statement (quarterly, 2025-09-30) — +Total Revenue: 150487000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 40219000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 168783000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -84103000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 301893000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -13441000.00
ORGO cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: 842000.00
ORGO cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: 842000.00
ORGO cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 922000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Assets Held For Sale Current: 4365000.00
ORGO income_statement (quarterly, 2025-09-30) — Basic Average Shares: 126881709.00
ORGO income_statement (quarterly, 2025-09-30) — Basic EPS: 0.11
ORGO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 73735000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Buildings And Improvements: 0.00
ORGO cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -2235000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 40810000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 130864000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 63745000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 63745000.00
ORGO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -10207000.00
ORGO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -2235000.00
ORGO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 3079000.00
ORGO cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -994000.00
ORGO cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 11943000.00
ORGO cash_flow (quarterly, 2025-09-30) — Change In Inventory: 938000.00
ORGO cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: 1432000.00
ORGO cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -2155000.00
ORGO cash_flow (quarterly, 2025-09-30) — Change In Payable: -994000.00
ORGO cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 10949000.00
ORGO cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 9644000.00
ORGO cash_flow (quarterly, 2025-09-30) — Change In Receivables: -50688000.00
ORGO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -29880000.00
ORGO cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -50688000.00
ORGO cash_flow (quarterly, 2025-09-30) — Changes In Cash: -9363000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Common Stock: 13000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 255128000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 27542000.00
ORGO income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 36251000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 4026000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Current Assets: 299749000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 9790000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 9790000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 2946000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 2946000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 90319000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Current Provisions: 497000.00
ORGO cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: -3837000.00
ORGO cash_flow (quarterly, 2025-09-30) — Deferred Tax: -3837000.00
ORGO cash_flow (quarterly, 2025-09-30) — Depreciation: 6145000.00
ORGO cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 6987000.00
ORGO cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 6987000.00
ORGO income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 130848995.00
ORGO income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.11
ORGO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 14525000.00
ORGO income_statement (quarterly, 2025-09-30) — EBIT: 21649000.00
ORGO income_statement (quarterly, 2025-09-30) — EBITDA: 28636000.00
ORGO cash_flow (quarterly, 2025-09-30) — End Cash Position: 64372000.00
ORGO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -10207000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Finished Goods: 24367000.00
ORGO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 844000.00
ORGO cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of PPE: 29000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Goodwill: 28772000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 38715000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 182224000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Gross PPE: 195465000.00
ORGO income_statement (quarterly, 2025-09-30) — Gross Profit: 114236000.00
ORGO income_statement (quarterly, 2025-09-30) — Impairment Of Capital Assets: 922000.00
ORGO cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 295000.00
ORGO income_statement (quarterly, 2025-09-30) — Interest Income: 415000.00
ORGO income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 415000.00
ORGO cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 0.00
ORGO balance_sheet (quarterly, 2025-09-30) — Inventory: 39583000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 255128000.00
ORGO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -2235000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Leases: 66727000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 31020000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 31020000.00
ORGO cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -296000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 67892000.00
ORGO income_statement (quarterly, 2025-09-30) — Net Income: 21567000.00
ORGO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 14525000.00
ORGO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 21567000.00
ORGO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 21567000.00
ORGO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 21567000.00
ORGO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 21567000.00
ORGO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 21567000.00
ORGO income_statement (quarterly, 2025-09-30) — Net Interest Income: 415000.00
ORGO cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -296000.00
ORGO cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -296000.00
ORGO income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 415000.00
ORGO cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -10041000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Net PPE: 111362000.00
ORGO cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -2235000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 347264000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 45591000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 45591000.00
ORGO income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 29558000.00
ORGO income_statement (quarterly, 2025-09-30) — Normalized Income: 22295380.00
ORGO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 3079000.00
ORGO cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 29000.00
ORGO income_statement (quarterly, 2025-09-30) — Operating Income: 21649000.00
ORGO income_statement (quarterly, 2025-09-30) — Operating Revenue: 150487000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 126911442.00
ORGO balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 22646000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 1252000.00
ORGO income_statement (quarterly, 2025-09-30) — Other Income Expense: -904000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 9943000.00
ORGO cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 1939000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 14410000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 2509000.00
ORGO income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 18000.00
ORGO income_statement (quarterly, 2025-09-30) — Other Operating Expenses: -377000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Other Properties: 33304000.00
ORGO income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 4308000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Payables: 40395000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 44421000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 31413000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 130851000.00
ORGO income_statement (quarterly, 2025-09-30) — Preferred Stock Dividends: 2734000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Preferred Stock Equity: 130851000.00
ORGO income_statement (quarterly, 2025-09-30) — Pretax Income: 21160000.00
ORGO cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 130000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
ORGO cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: 2287000.00
ORGO cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -2235000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Raw Materials: 14094000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Receivables: 168783000.00
ORGO income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 36251000.00
ORGO income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 6987000.00
ORGO cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -296000.00
ORGO income_statement (quarterly, 2025-09-30) — Research And Development: 13221000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 627000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -46778000.00
ORGO income_statement (quarterly, 2025-09-30) — Selling General And Administration: 79743000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Share Issued: 127639990.00
ORGO income_statement (quarterly, 2025-09-30) — Special Income Charges: -922000.00
ORGO cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 3065000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 385979000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 216413000.00
ORGO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -193620.00
ORGO income_statement (quarterly, 2025-09-30) — Tax Provision: -407000.00
ORGO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
ORGO balance_sheet (quarterly, 2025-09-30) — Total Assets: 509827000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 385979000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Total Debt: 40810000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 385979000.00
ORGO income_statement (quarterly, 2025-09-30) — Total Expenses: 128838000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 123848000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 210078000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 33529000.00
ORGO income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 20727000.00
ORGO income_statement (quarterly, 2025-09-30) — Total Other Finance Cost: -415000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 176000.00
ORGO income_statement (quarterly, 2025-09-30) — Total Unusual Items: -922000.00
ORGO income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -922000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 728548.00
ORGO balance_sheet (quarterly, 2025-09-30) — Work In Process: 1122000.00
ORGO balance_sheet (quarterly, 2025-09-30) — Working Capital: 209430000.00
ORGO income_statement (quarterly, 2025-09-30) — Write Off: 0.00
ORGO income_statement (annual, 2025-12-31) — +Operating Expense: 369639000.00
ORGO income_statement (quarterly, 2025-12-31) — +Operating Expense: 109924000.00
ORGO income_statement (annual, 2025-12-31) — +Total Revenue: 563030000.00
ORGO income_statement (quarterly, 2025-12-31) — +Total Revenue: 225071000.00
ORGO balance_sheet (annual, 2025-12-31) — Accounts Payable: 31949000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 31949000.00
ORGO balance_sheet (annual, 2025-12-31) — Accounts Receivable: 217451000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 217451000.00
ORGO balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -88107000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -88107000.00
ORGO balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 303194000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 303194000.00
ORGO balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -16089000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -16089000.00
ORGO cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 3323000.00
ORGO cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 798000.00
ORGO cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 3323000.00
ORGO cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 798000.00
ORGO cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 11175000.00
ORGO cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 1940000.00
ORGO balance_sheet (annual, 2025-12-31) — Assets Held For Sale Current: 2425000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Assets Held For Sale Current: 2425000.00
ORGO income_statement (annual, 2025-12-31) — Basic Average Shares: 126738136.00
ORGO income_statement (quarterly, 2025-12-31) — Basic Average Shares: 126913293.00
ORGO income_statement (annual, 2025-12-31) — Basic EPS: 0.16
ORGO income_statement (quarterly, 2025-12-31) — Basic EPS: 0.25
ORGO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 136151000.00
ORGO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 64372000.00
ORGO balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 0.00
ORGO balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 0.00
ORGO cash_flow (annual, 2025-12-31) — Capital Expenditure: -14151000.00
ORGO cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -4652000.00
ORGO balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 82137000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 82137000.00
ORGO balance_sheet (annual, 2025-12-31) — Capital Stock: 133802000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 133802000.00
ORGO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 93679000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 93679000.00
ORGO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 93679000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 93679000.00
ORGO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -17360000.00
ORGO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -4809000.00
ORGO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -14151000.00
ORGO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -4652000.00
ORGO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -10309000.00
ORGO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 39420000.00
ORGO cash_flow (annual, 2025-12-31) — Change In Account Payable: -528000.00
ORGO cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -1171000.00
ORGO cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 10381000.00
ORGO cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 12324000.00
ORGO cash_flow (annual, 2025-12-31) — Change In Inventory: -17915000.00
ORGO cash_flow (quarterly, 2025-12-31) — Change In Inventory: -2961000.00
ORGO cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 158000.00
ORGO cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -1308000.00
ORGO cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -8491000.00
ORGO cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -2189000.00
ORGO cash_flow (annual, 2025-12-31) — Change In Payable: -528000.00
ORGO cash_flow (quarterly, 2025-12-31) — Change In Payable: -1171000.00
ORGO cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 9853000.00
ORGO cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 11153000.00
ORGO cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -183000.00
ORGO cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 3115000.00
ORGO cash_flow (annual, 2025-12-31) — Change In Receivables: -115803000.00
ORGO cash_flow (quarterly, 2025-12-31) — Change In Receivables: -51478000.00
ORGO cash_flow (annual, 2025-12-31) — Change In Working Capital: -132381000.00
ORGO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -43668000.00
ORGO cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -115803000.00
ORGO cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -51478000.00
ORGO cash_flow (annual, 2025-12-31) — Changes In Cash: -41820000.00
ORGO cash_flow (quarterly, 2025-12-31) — Changes In Cash: 29959000.00
ORGO balance_sheet (annual, 2025-12-31) — Common Stock: 13000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Common Stock: 13000.00
ORGO balance_sheet (annual, 2025-12-31) — Common Stock Equity: 300129000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 300129000.00
ORGO cash_flow (annual, 2025-12-31) — Common Stock Payments: 0.00
ORGO balance_sheet (annual, 2025-12-31) — Construction In Progress: 26743000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 26743000.00
ORGO income_statement (annual, 2025-12-31) — Cost Of Revenue: 137522000.00
ORGO income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 49918000.00
ORGO balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 1698000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 1698000.00
ORGO balance_sheet (annual, 2025-12-31) — Current Assets: 362188000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Current Assets: 362188000.00
ORGO balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 18642000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 18642000.00
ORGO balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 18642000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 18642000.00
ORGO balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 3861000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 3861000.00
ORGO balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 3861000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 3861000.00
ORGO balance_sheet (annual, 2025-12-31) — Current Liabilities: 100124000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 100124000.00
ORGO cash_flow (annual, 2025-12-31) — Deferred Income Tax: 9500000.00
ORGO cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 15629000.00
ORGO cash_flow (annual, 2025-12-31) — Deferred Tax: 9500000.00
ORGO cash_flow (quarterly, 2025-12-31) — Deferred Tax: 15629000.00
ORGO cash_flow (annual, 2025-12-31) — Depreciation: 23615000.00
ORGO cash_flow (quarterly, 2025-12-31) — Depreciation: 6215000.00
ORGO cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 26938000.00
ORGO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 7013000.00
ORGO cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 26938000.00
ORGO cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 7013000.00
ORGO income_statement (annual, 2025-12-31) — Diluted Average Shares: 130248412.00
ORGO income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 132206983.00
ORGO income_statement (annual, 2025-12-31) — Diluted EPS: 0.15
ORGO income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.24
ORGO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 20022000.00
ORGO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 35122000.00
ORGO income_statement (annual, 2025-12-31) — EBIT: 55869000.00
ORGO income_statement (quarterly, 2025-12-31) — EBIT: 65229000.00
ORGO income_statement (annual, 2025-12-31) — EBITDA: 82807000.00
ORGO income_statement (quarterly, 2025-12-31) — EBITDA: 72242000.00
ORGO cash_flow (annual, 2025-12-31) — End Cash Position: 94331000.00
ORGO cash_flow (quarterly, 2025-12-31) — End Cash Position: 94331000.00
ORGO cash_flow (annual, 2025-12-31) — Financing Cash Flow: -17360000.00
ORGO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -4809000.00
ORGO balance_sheet (annual, 2025-12-31) — Finished Goods: 14023000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Finished Goods: 14023000.00
ORGO cash_flow (annual, 2025-12-31) — Free Cash Flow: -24460000.00
ORGO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 34768000.00
ORGO cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: 188000.00
ORGO cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: 115000.00
ORGO balance_sheet (annual, 2025-12-31) — Goodwill: 28772000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Goodwill: 28772000.00
ORGO balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 37917000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 37917000.00
ORGO balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 233540000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 233540000.00
ORGO balance_sheet (annual, 2025-12-31) — Gross PPE: 247567000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Gross PPE: 247567000.00
ORGO income_statement (annual, 2025-12-31) — Gross Profit: 425508000.00
ORGO income_statement (quarterly, 2025-12-31) — Gross Profit: 175153000.00
ORGO income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 11175000.00
ORGO income_statement (quarterly, 2025-12-31) — Impairment Of Capital Assets: 1940000.00
ORGO cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 5346000.00
ORGO cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 1260000.00
ORGO income_statement (annual, 2025-12-31) — Interest Income: 2281000.00
ORGO income_statement (annual, 2025-12-31) — Interest Income Non Operating: 2281000.00
ORGO cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 0.00
ORGO cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 0.00
ORGO balance_sheet (annual, 2025-12-31) — Inventory: 29627000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Inventory: 29627000.00
ORGO balance_sheet (annual, 2025-12-31) — Invested Capital: 300129000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Invested Capital: 300129000.00
ORGO cash_flow (annual, 2025-12-31) — Investing Cash Flow: -14151000.00
ORGO cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -4652000.00
ORGO cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 0.00
ORGO balance_sheet (annual, 2025-12-31) — Leases: 67866000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Leases: 67866000.00
ORGO balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 63495000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 63495000.00
ORGO balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 63495000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 63495000.00
ORGO cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -1171000.00
ORGO cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -302000.00
ORGO balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 69233000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 69233000.00
ORGO cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 0.00
ORGO income_statement (annual, 2025-12-31) — Net Income: 37032000.00
ORGO income_statement (quarterly, 2025-12-31) — Net Income: 43700000.00
ORGO income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 20022000.00
ORGO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 35122000.00
ORGO income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 37032000.00
ORGO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 43700000.00
ORGO income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 37032000.00
ORGO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 43700000.00
ORGO income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 37032000.00
ORGO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 43700000.00
ORGO cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 37032000.00
ORGO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 43700000.00
ORGO income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 37032000.00
ORGO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 43700000.00
ORGO income_statement (annual, 2025-12-31) — Net Interest Income: 2281000.00
ORGO income_statement (quarterly, 2025-12-31) — Net Interest Income: 236000.00
ORGO cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -1171000.00
ORGO cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -302000.00
ORGO cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -1171000.00
ORGO cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -302000.00
ORGO income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 2281000.00
ORGO income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 236000.00
ORGO cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -16346000.00
ORGO cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -4509000.00
ORGO balance_sheet (annual, 2025-12-31) — Net PPE: 159460000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Net PPE: 159460000.00
ORGO cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -14151000.00
ORGO cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -4652000.00
ORGO cash_flow (annual, 2025-12-31) — Net Preferred Stock Issuance: 0.00
ORGO balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 396001000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 396001000.00
ORGO balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 29962000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 29962000.00
ORGO balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 29962000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 29962000.00
ORGO income_statement (annual, 2025-12-31) — Normalized EBITDA: 93982000.00
ORGO income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 74182000.00
ORGO income_statement (annual, 2025-12-31) — Normalized Income: 45837900.00
ORGO income_statement (quarterly, 2025-12-31) — Normalized Income: 45036623.20
ORGO cash_flow (annual, 2025-12-31) — Operating Cash Flow: -10309000.00
ORGO cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 39420000.00
ORGO cash_flow (annual, 2025-12-31) — Operating Gains Losses: 188000.00
ORGO cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 115000.00
ORGO income_statement (annual, 2025-12-31) — Operating Income: 55869000.00
ORGO income_statement (quarterly, 2025-12-31) — Operating Income: 65229000.00
ORGO income_statement (annual, 2025-12-31) — Operating Revenue: 563030000.00
ORGO income_statement (quarterly, 2025-12-31) — Operating Revenue: 225071000.00
ORGO balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 126951876.00
ORGO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 126951876.00
ORGO balance_sheet (annual, 2025-12-31) — Other Current Assets: 7389000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 7389000.00
ORGO balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 1260000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 1260000.00
ORGO income_statement (annual, 2025-12-31) — Other Income Expense: -11180000.00
ORGO income_statement (quarterly, 2025-12-31) — Other Income Expense: -2038000.00
ORGO balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 9145000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 9145000.00
ORGO cash_flow (annual, 2025-12-31) — Other Non Cash Items: 15728000.00
ORGO cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 7557000.00
ORGO balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 9203000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 9203000.00
ORGO balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 1193000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 1193000.00
ORGO income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -5000.00
ORGO income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -98000.00
ORGO income_statement (annual, 2025-12-31) — Other Operating Expenses: -1139000.00
ORGO income_statement (quarterly, 2025-12-31) — Other Operating Expenses: -536000.00
ORGO balance_sheet (annual, 2025-12-31) — Other Properties: 83725000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Other Properties: 83725000.00
ORGO income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 6180000.00
ORGO income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 5790000.00
ORGO balance_sheet (annual, 2025-12-31) — Payables: 31949000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Payables: 31949000.00
ORGO balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 33647000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 33647000.00
ORGO balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 42714000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 42714000.00
ORGO balance_sheet (annual, 2025-12-31) — Preferred Stock: 133789000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 133789000.00
ORGO income_statement (annual, 2025-12-31) — Preferred Stock Dividends: 10830000.00
ORGO income_statement (quarterly, 2025-12-31) — Preferred Stock Dividends: 2788000.00
ORGO balance_sheet (annual, 2025-12-31) — Preferred Stock Equity: 133789000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Preferred Stock Equity: 133789000.00
ORGO cash_flow (annual, 2025-12-31) — Preferred Stock Issuance: 0.00
ORGO balance_sheet (annual, 2025-12-31) — Prepaid Assets: 10965000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 10965000.00
ORGO income_statement (annual, 2025-12-31) — Pretax Income: 46970000.00
ORGO income_statement (quarterly, 2025-12-31) — Pretax Income: 63427000.00
ORGO cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 157000.00
ORGO cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 2000.00
ORGO balance_sheet (annual, 2025-12-31) — Properties: 0.00
ORGO balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
ORGO cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 8213000.00
ORGO cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: 2810000.00
ORGO cash_flow (annual, 2025-12-31) — Purchase Of PPE: -14151000.00
ORGO cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -4652000.00
ORGO balance_sheet (annual, 2025-12-31) — Raw Materials: 14339000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Raw Materials: 14339000.00
ORGO balance_sheet (annual, 2025-12-31) — Receivables: 217451000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Receivables: 217451000.00
ORGO income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 137522000.00
ORGO income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 49918000.00
ORGO income_statement (annual, 2025-12-31) — Reconciled Depreciation: 26938000.00
ORGO income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 7013000.00
ORGO cash_flow (annual, 2025-12-31) — Repayment Of Debt: -1171000.00
ORGO cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -302000.00
ORGO cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: 0.00
ORGO income_statement (annual, 2025-12-31) — Research And Development: 44542000.00
ORGO income_statement (quarterly, 2025-12-31) — Research And Development: 10286000.00
ORGO balance_sheet (annual, 2025-12-31) — Restricted Cash: 652000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 652000.00
ORGO balance_sheet (annual, 2025-12-31) — Retained Earnings: -3078000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -3078000.00
ORGO income_statement (annual, 2025-12-31) — Selling General And Administration: 326236000.00
ORGO income_statement (quarterly, 2025-12-31) — Selling General And Administration: 100174000.00
ORGO balance_sheet (annual, 2025-12-31) — Share Issued: 127680424.00
ORGO balance_sheet (quarterly, 2025-12-31) — Share Issued: 127680424.00
ORGO income_statement (annual, 2025-12-31) — Special Income Charges: -11175000.00
ORGO income_statement (quarterly, 2025-12-31) — Special Income Charges: -1940000.00
ORGO cash_flow (annual, 2025-12-31) — Stock Based Compensation: 13298000.00
ORGO cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 4324000.00
ORGO balance_sheet (annual, 2025-12-31) — Stockholders Equity: 433918000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 433918000.00
ORGO balance_sheet (annual, 2025-12-31) — Tangible Book Value: 262212000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 262212000.00
ORGO income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -2369100.00
ORGO income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -603376.80
ORGO income_statement (annual, 2025-12-31) — Tax Provision: 9938000.00
ORGO income_statement (quarterly, 2025-12-31) — Tax Provision: 19727000.00
ORGO income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
ORGO income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.31
ORGO balance_sheet (annual, 2025-12-31) — Total Assets: 598730000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Total Assets: 598730000.00
ORGO balance_sheet (annual, 2025-12-31) — Total Capitalization: 433918000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 433918000.00
ORGO balance_sheet (annual, 2025-12-31) — Total Debt: 82137000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Total Debt: 82137000.00
ORGO balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 433918000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 433918000.00
ORGO income_statement (annual, 2025-12-31) — Total Expenses: 507161000.00
ORGO income_statement (quarterly, 2025-12-31) — Total Expenses: 159842000.00
ORGO balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 164812000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 164812000.00
ORGO balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 236542000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 236542000.00
ORGO balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 64688000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 64688000.00
ORGO income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 44694000.00
ORGO income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 63289000.00
ORGO balance_sheet (annual, 2025-12-31) — Total Tax Payable: 0.00
ORGO balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 0.00
ORGO income_statement (annual, 2025-12-31) — Total Unusual Items: -11175000.00
ORGO income_statement (quarterly, 2025-12-31) — Total Unusual Items: -1940000.00
ORGO income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -11175000.00
ORGO income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -1940000.00
ORGO balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 728548.00
ORGO balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 728548.00
ORGO balance_sheet (annual, 2025-12-31) — Work In Process: 1265000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Work In Process: 1265000.00
ORGO balance_sheet (annual, 2025-12-31) — Working Capital: 262064000.00
ORGO balance_sheet (quarterly, 2025-12-31) — Working Capital: 262064000.00
ORGO income_statement (annual, 2025-12-31) — Write Off: 0.00
ORGO income_statement (quarterly, 2025-12-31) — Write Off: 0.00
ORGO income_statement (quarterly, 2026-03-31) — +Operating Expense: 79369000.00